Davcera provides access to clinician-supervised peptide protocols, TRT, HRT, and NAD+ programs — delivered through licensed providers and 503A compounding pharmacies.
By joining you agree to our Privacy Policy. US residents only.
Each program is clinician-supervised and delivered through licensed providers and 503A compounding pharmacies.
Davcera is a longevity telehealth platform that provides clinician-supervised peptide protocols, hormonal optimization programs, and NAD+ protocols for US residents. All programs are prescribed by independent licensed healthcare providers and guided by your lab results.
Davcera offers three core programs: Peptide Protocols (including BPC-157, Ipamorelin, GHK-Cu, TB-500), TRT & HRT (testosterone, estrogen, progesterone, DHEA), and NAD+ & Cellular Health programs.
Davcera is currently available to US residents only. All programs require clinical evaluation by a licensed healthcare provider and are subject to state-specific telehealth regulations. Availability by state will be confirmed during onboarding.
All Davcera programs are clinician-supervised and require a full clinical evaluation before any protocol is prescribed. Compounds are prepared at licensed 503A pharmacies meeting USP 797/795 standards. Individual results may vary. Nothing here constitutes medical advice — consult your healthcare provider.
Davcera is currently in early access. Join the waitlist below to be among the first notified when full access becomes available. Early access members receive priority onboarding and exclusive launch pricing.
Join the Davcera waitlist and be among the first to access clinician-supervised longevity protocols when we launch.
By joining you agree to our Privacy Policy. US residents only.